Branching morphogenesis
Introduction
The development of the metanephric kidney, the permanent mammalian kidney, requires ureteric budding, reciprocal interactions between the ureteric bud (UB) epithelium and the metanephric mesenchyme (MM), branching morphogenesis and nephrogenesis. Defects in these processes can result in hypoplasia with low nephron endowment which is a risk factor for the development of hypertension and chronic kidney disease in adulthood (Abitbol and Ingelfinger, 2009) .
Global gene knockout studies have helped identify a number of genes that are important in kidney development (www.gudmap.org) (Costantini and Kopan, 2010; Dressler, 2009; Little et al., 2010) . Further investigation of these developmental genes in a cell and time-specific manner are necessary to gain insights into how these genes and downstream pathways can be manipulated to alter the course of kidney diseases resulting from their deficiencies.
Glial cell line-derived neurotrophic factor (GDNF) coreceptor a1 (GFRa1) is a major protein that is essential for early UB induc-0925-4773/$ -see front matter Ó 2013 Elsevier Ireland Ltd. All rights reserved. http://dx.doi.org/10.1016/j.mod.2013.03.001 tion and kidney development as global Gfra1-knockout mice die at birth due to renal agenesis (Cacalano et al., 1998; Enomoto et al., 1998) . This has hampered further studies of the role of Gfra1 in later renal development. GFRa1 is the high affinity co-receptor for GDNF. GFRa1 is anchored to the cell surface by glycosylphophatidyl inositol (GPI) linkage. It localizes to lipid rafts within the cell membrane and the binding of GDNF recruits the receptor tyrosine kinase rearranged during transfection (RET). Among the four GFRa coreceptors (GFRa1-4) and four GDNF family ligands (GFLs, GDNF, Neurteurin, Atremin and Persephin), the receptor complex consisting of dimers of GFRa1-GDNF with RET is the physiologically relevant signaling unit during kidney and enteric nervous system development (Saarma, 2000) . This three protein complex of GDNF, GFRa1, and RET activates the phosphorylation of specific tyrosine residues in the intracellular domain of RET. This results in activation of downstream signaling pathways such as PLCc, PI3K, and/or MAPK that have been shown to be necessary for early embryonic kidney development (Jain, 2009; Jain et al., 2006a) .
Gfra1 mRNA is expressed in both the ureteric epithelium and the MM during branching morphogenesis (Enomoto et al., 2004; Golden et al., 1999; Towers et al., 1998) . Thus, it is more widely expressed than either Gdnf or Ret during kidney development. The biological significance of this wider and persistent expression after UB induction is not clear. A number of studies in vitro suggest that GFRa1/GDNF/RET tyrosine kinase signaling has a role in branching morphogenesis, a process that occurs after UB induction -reviewed in (Costantini and Shakya, 2006) . However, evidence in vivo for the role of this pathway in later metanephric development is lacking. Another interesting aspect of Gfra1 is that it can act in trans in neurological tissues (Ledda et al., 2002; Paratcha et al., 2001) . The physiological role of trans-signaling by Gfra1 in kidney development is not known.
Here we generated unique Gfra1 reporter and Cre-deletor strains to conditionally examine Gfra1's role in the epithelia cell in pre and post UB kidney development. We found that Gfra1 was expressed in the mesonephric mesenchyme and Wolffian duct (WD) before UB induction and in the MM and UB epithelium during branching morphogenesis. Expression of Gfra1 in the urinary epithelium is critical for UB induction and has a modest role after UB induction during early branching morphogenesis.
Results

Gfra1 is expressed early in kidney development and throughout branching morphogenesis
To obtain a clear understanding of Gfra1 expression in the urinary tract during development we generated a Gfra1 reporter mouse that expresses the enhanced green fluorescent protein (EGFP) from the Gfra1 locus (Gfra1 EGFP/+ ) (Uesaka et al., 2007) (Fig. 1A) . Robust EGFP signal, indicative of Gfra1 expression, was identified throughout the developing WD at E9.5 (Fig. 1B) . At E10.5, Gfra1 expression was identified in the WD with greater localization to the caudal UB budding domain, as well as in the mesonephric mesenchyme and the cranial mesonephric tubules (future epididymis in males) (Fig. 1C) . At E11.5, the Tshape stage of branching morphogenesis, Gfra1-positive cells were present in the UB stalk and in the distal UB tips ( Fig. 1D and E). There was faint expression of Gfra1 in the metanephric mesenchyme (MM) at E11.5 (Fig. 1E ) that becomes more prominent as the MM condenses around the UB tip (Fig. 1F) . At E13.5, consistent with previously reported mRNA expression of Gfra1, we detected Gfra1-positive cells in the ''cap'' mesenchyme in addition to the ureteric epithelium ( Fig. 1G-I) (Enomoto et al., 2004; Golden et al., 1999; Towers et al., 1998) . At E15.5 strong EGFP expression was seen in the developing kidney by whole mount immunohistochemistry (Fig. 1J) . High resolution images ( Fig. 1K and M) confirm both UB tip and cap mesenchyme expression. Thereafter, Gfra1 continues to be expressed in the developing kidney both in the ureteric stalk (collecting duct), bud tip and the surrounding cap mesenchyme (Fig. 1N and O). We performed double label immunohistochemistry with anti-Gfra1and anti-EGFP antibodies to confirm that EGFP expression recapitulated Gfra1 expression (Fig. 1P-R ). These observations support that Gfra1 has a broader expression in the metanephric kidney than either Ret or Gdnf (Enomoto et al., 2004; Golden et al., 1999; Sainio et al., 1997; Towers et al., 1998) and demonstrate that Gfra1 is expressed before UB induction in both the Wolffian Duct (WD) and the surrounding mesonephric mesenchyme.
2.2.
Gfra1 expression in the collecting system primordia is indispensable for metanephric kidney formation Previous studies have demonstrated that forced expression of Gfra1 from the Ret locus while eliminating it from non-Ret expressing sites is sufficient for normal kidney development (Enomoto et al., 2004) . This suggested that trans-Gfra1 expression is dispensable if Gfra1 is expressed in a cell-autonomous manner. However, non-epithelial expression of Gfra1 in other organ systems has shown that it can act in a paracrine manner, so called ''trans-signaling,'' to activate Ret signal transduction (Ledda et al., 2002; Paratcha et al., 2001) . Therefore, we sought to determine if Gfra1 from sites other than the urinary epithelium are able to compensate and support normal kidney development. We used the Cre-deletor strain Hoxb7-Cre (Yu et al., 2002 ) to achieve WD-specific deletion of Gfra1 in mice harboring a Gfra1-conditional reporter allele Gfra1 floxEGFP (Uesaka et al., 2007) (Fig. 2A) . All Gfra1 floxEGFP/À :Hoxb7Cre pups, which have Gfra1 deleted in the urinary tract epithelium, had kidney defects. The majority had bilateral renal agenesis/aplasia (16/ 20) and three had unilateral agenesis and contralateral megaureter ( Fig. 2B and Table 1 ). These findings reveal unequivocally that Gfra1 in the WD/urinary epithelium is indispensable and is the mechanism for renal agenesis in global Gfra1-null mice. Further, trans-Gfra1 in early stages of kidney development cannot compensate for its loss in the WD.
2.3.
Conditional deletion of Gfra1 after initial UB budding using a tamoxifen inducible Cre strain After determining that Gfra1 is required in the WD during early kidney development and that it is expressed throughout metanephric development we next established an inducible system to delete Gfra1 after UB induction. To accomplish this, we generated a mouse strain that expresses the tamoxifen inducible Cre recombinase (CreERT2) from the Gfra1 locus (Gfra1-CreERT2). The heterozygous Gfra1
CreERT2/+ mice were viable and fertile. The advantage of this mouse line is that a single cross with Gfra1 conditional mice yields desired progeny expressing only the Gfra1 conditional allele that can be excised with tamoxifen inducible Cre (Gfra1
) and this will be referred to as Gfra1CKO (Fig. 3A) . Furthermore, excision of Gfra1 is indicated by the EGFP signal which facilitates interpretation of the resulting phenotypes due to Gfra1 loss (Uesaka et al., 2007) . We performed a series of experiments to determine the efficiency of Gfra1 excision in vivo in the kidney after 4-hydroxytamoxifen (4HT) expo- [(D), low power; (E), high power] At E11.5 strong Gfra1 expression is seen in the induced UB and in the stalk. Gfra1 is also expressed, although at much lower levels, in the metanephric mesenchyme (MM). (F) Metanephric kidney harvested at E11.5 and cultured for 24 h continues to show expression in the ureteric epithelium with strong expression in the UB tips and weaker expression in the cap mesenchyme (CapM) condensing around the UB tips. Boxed region is displayed at higher magnification (right). (G-I) Gfra1 is expressed in E13.5 metanephroi at strong levels in the UB tips, and weakly in the stalk and cap mesenchyme. Whole mount direct immunofluorescence image is shown in G, anti-GFP immunofluorescence on paraffin embedded sections in H (low power), and I (high power) show UB tip, stalk and CapM expression. The expression in the mesenchyme (arrow) is directly adjacent to and surrounding the distal UB tip (asterisk). (J-M) Gfra1 expression in E15.5 whole mount kidneys. J, whole mount, and K-M are high power images of EGFP, anti-Ecadherin (Ecad, white, epithelium) and merged immunostained images of UB tip (asterisks) demonstrating Gfra1 expression (green) in UB tip and cap mesenchyme (CapM) . (N,O) At postnatal day 0 (P0), Gfra1 continues to be expressed in the kidney with high expression in the UB tips. (P-R) Double EGFP-Gfra1 immunolabeling on paraffin sections at E13.5 confirm that EGFP reporter recapitulates Gfra1 expression in the UB tip and CapM. Scale bar: B-D, 500 lm; E, 50 lm; F, 250 lm, high power UB tip at 50 lm; G, 200 lm; H, 100 lm; I, 50 lm; J, 500 lm; K-M, 50 lm; N, 500 lm; O, 50 lm; P-R, 10 lm. Native fluorescence was used to visualize Gfra1 expression in panels B-G, J, N and O. Anti-GFP immunostaining was used in H, I, K and P to visualize Gfra1 expression.
sure (see Section 4). Whole mount live images of Gfra1CKO embryos 2 days after 4HT injection showed strong EGFP signal indicating successful Gfra1 excision (Fig. 3B) . Using combination of E-cadherin (epithelial marker), Gfra1 and GFP immunostaining on metanephric kidney sections, we were able to determine complete elimination of Gfra1 in more than 65% of UB tip cells after UB induction (Fig. 3C ) although the excisional efficiency in the MM was much lower due to weak expression. With a similar level of inducible deletion (70%) in the gut we previously discovered that Gfra1 is required for survival of enteric neurons as its conditional deletion resulted in complete aganglionosis (Uesaka et al., 2007) . We performed quantitative RTPCR analysis and found that total Gfra1 mRNA was reduced by 76% in E14.5 kidneys after conditional deletion compared to the wild-type kidneys (Fig. 3D ).
The residual Gfra1 mRNA represents expression of the unexcised Gfra1 in the UB tip and MM cells.
2.4.
Gfra1 conditional loss does not alter mRNA levels of several of the genes in the Ret pathway
We next examined if reduced Gfra1 post UB induction affected expression of positive and negative regulators of Ret signaling and branching morphogenesis: Ret, Gdnf, Wnt11, Sprouty1, Gfra2, Fgf10, Fgf2r, and Etv4 (Costantini and Kopan, 2010; Majumdar et al., 2003; Pepicelli et al., 1997) . Although Ret mRNA expression decreased by about 50%, Gdnf, Wnt11, and Etv4 mRNAs were not significantly affected at E14.5 (Fig. 3D ). Studies in vitro have shown that Gfra2 can also bind to Gdnf and activate Ret (Sariola and Saarma, 2003) . However, The genotypes and phenotypes of 7 separate litters. ** Of the 55 heterozygous one pup had right mild hydronephrosis and the other had right bifurcated ureter.
physiological levels of Gfra2 are not able to compensate for Gfra1 loss in the urinary tract as Gfra1 nulls have renal agenesis. We investigated if there were compensatory changes in Gfra2 expression in the Gfra1CKO mice that could explain near normal expression of Ret associated downstream genes in Gfra1CKO mice. There was no difference in Gfra2 mRNA expression between Gfra1CKO and wild-type kidneys. Furthermore, there was no significant difference in the expression levels of mRNAs for receptor tyrosine kinase Fgfr2, or its ligand Fgf10 or in the negative tyrosine kinase regulator Sprouty1.
Gfra1 loss after UB induction results in a modest decrease in kidney size
To determine the role of Gfra1 in the ureteric epithelium after UB induction we treated pregnant mice with 4HT at E11.5-12.5 and analyzed kidneys of the Gfra1CKO and control littermate embryos at E14.5 or at E16.5-E17.5 ( Fig. 4A-E ). The loss of Gfra1 resulted in a 20% reduction in kidney size compared to littermate controls at E16.5-17.5 (Fig. 4B ). Histological assessment of Gfra1CKO kidneys showed a well-defined cortex and medulla (Fig. 4C ). The nephrogenic zone did not exhibit any overt defects. To further confirm if reduced branching is the cause of hypoplasia we performed whole mount immunohistochemistry using the epithelial marker E-cadherin at different time points (Fig. 4D and Supplemental Fig. 1 ). Quantitative analysis of the UB tips at E14.5 and E16.5-17.5 showed a significant, although modest, reduction in the number of UB tips (Fig. 4E) . Interestingly, a consistent finding in these kidneys were dilated UB ampullae (Fig. 4D) . This phenotype has also been reported in kidneys that lack Gdnf and Sprouty1 or Ret and Sprouty1 (Michos et al., 2010) suggesting that GdnfGfra1-Ret signaling after UB induction may be important in maintaining normal ampulla morphology or it may represent image shows live EGFP signal in E13.5 kidney dissected 2 days after 4HT treatment illustrating successful Gfra1 deletion. (C) Double immunofluorescence of E14.5 ureteric buds with anti-GFP (green) and anti-Gfra1 (red) antibodies illustrate Gfra1 excision in the majority of UB tip epithelial cells (green arrows). Cells with no excision stain with Gfra1 (red arrows). Asterisks denote metanephric mesenchyme. (D) mRNA expression of selected genes using quantitative real time PCR on whole kidney lysates of Gfra1CKO relative to control mice at E14.5. Control n = 6 (12 kidneys); Gfra1CKO n = 7 (14 kidneys). Note marked reduction in Gfra1 expression (mean ± s.e.m., * P < 0.001, t-test) in Gfra1CKO kidneys. Scale bar 500 lm in B; 50 lm in C.
a delay in development as the ampulla size decreases with age (Supplemental Fig. 1 ).
Conditional Gfra1 loss post UB-induction affects UB tip proliferation and ERK activity
To determine if altered proliferation is the cause of reduced branching and hypoplasia we performed anti-phosphohistone H3 immunohistochemistry on E14.5 kidney sections ( Fig. 5A and B) . The overall UB tip mitotic index was significantly higher (3.6 ± 0.3%) in the control animals compared with Gfra1CKO mice (2.5 ± 0.2%) (Fig. 5C ). This observation suggests that the reduction in kidney size is due to reduced UB tip proliferation in Gfra1CKO mice. To directly assess the impact of Gfra1 loss on cell proliferation in only Gfra1CKO mice we determined the mitotic index in UB tip cells that had no Gfra1 (1.7 ± 0.2%) and cells in which Gfra1 remained (6.3 ± 1.4%) (Fig. 5D ). This result supports that UB tip proliferation is only partly dependent on Gfra1 and the cells in which Gfra1 is not completely excised are able to compensate with increased proliferation. This compensation is consistent with the observation that we find less number of recombinant cells in the nephrogenic zone at E16.5 (Supplemental Fig. 2 ). Analysis of cell death by TUNEL staining did not reveal any significant difference between the control and Gfra1CKO groups (data not shown). We also examined phosphorylated-ERK (pERK) activity in Gfra1CKO mice because MAPK is one of the key pathways activated by Gdnf-Gfra1-Ret and it regulates cell proliferation during UB development (Hoshi et al., 2012) . In agreement with previous observations, the ). (B) Bar graph shows cross-sectional area of the Gfra1CKO metanephros are less than that of littermate controls (6 separate litters, control n = 11, Gfra1CKO n = 11; mean ± s.e.m., * P < 0.001 by t-test). (C) E17.5 Hematoxylin and Eosin stained sections depict preserved kidney architecture with well-formed cortex and medulla in Gfra1CKO mice. (D) Whole mount E-cadherin staining highlights the ureteric branching pattern in control and Gfra1CKO mice. Note decreased branching in Gfra1CKO and an apparent increase in ampullae dilation. (E) Bar graph illustrates reduced number of UB tips in Gfra1CKO kidneys compared to controls (mean ± s.e.m.; E14.5 Control n = 4, Gfra1CKO n = 4; * P < 0.03. E16.5-17.5 Control n = 11, Gfra1CKO n = 9; * P < 0.008). Scale bar 200 lm for all images.
percentage of pERK-positive cells was low in the branching UB tips at E14.5 in wildtype mice (Hu et al., 2011) . This is in contrast to a high percentage of pERK-positive cells in Wolffian duct epithelium at E10.5 (Hoshi et al., 2012 ) (Supplemental Fig. 3A and B) . We did not find a significant difference in the number of pERK-positive UB tip cells between controls (17.7 ± 2.7%) and Gfra1CKO (15.4 ± 1.9%) mice (Supplemental Fig. 3C-E) . Direct EGFP visualization in conjunction with pERK immunostaining showed that pERK was absent in virtually all the cells in which Gfra1 was conditionally deleted compared to controls ( Fig. 5E and F; Supplemental Fig. 3D ). We quantified the number of pERK-positive cells in Gfra1CKO UB tips which have lost Gfra1 (green) (1.5 ± 0.5%) versus adjacent cells in which Gfra1 remained (37.1 ± 3.6%) (Supplemental Fig. 3C ). These findings suggest that Gfra1 is a major regulator of ERK activity in UB tip cells.
2.7.
Explant cultures of metanephric kidneys with near complete Gfra1 loss show reduction in branching morphogenesis ) and mutant (Gfra1CKO) mice for E-cadherin (Ecad, epithelial marker), phosphohistone-H3 (phh3, proliferation marker), and green fluorescent protein (EGFP, represents Gfra1-negative cells). Arrows indicate phh3 staining in epithelial cells. (C) Graph illustrates decreased overall UB tip proliferation in Gfra1CKO kidneys and in cells with successful Gfra1 excision (black bar). Proliferation as evaluated by quantification of mitotic index from phh3 immunolabeled UB tips from E14.5 metanephric kidneys (2 days after tamoxifen administration) in littermate control and Gfra1CKO mice. (D) Cells in the UB tips of Gfra1CKO mice that have escaped Gfra1 excision exhibit higher proliferation rate compared to cells that have lost Gfra1 (Control n = 7, Gfra1CKO n = 11; mean ± s.e.m., * P < 0.01 by t-test). (E, F) Double-labeled Immunofluorescence images of UB tip cells on frozen section at E14.5 with anti-GFP denoting Gfra1 deletion (green, arrows) and antiphospho-ERK (red, arrows) in control (E) and 4HT-treated Gfra1CKO (F) mice. Merged image of mutant (F) on far right, illustrates limited overlap between green and red cells supporting the lack of p-ERK activity in EGFP (Gfra1 excised) positive cells. Scale bar 50 lm in all images.
Gfra1, the mild phenotype could be a result of incomplete excision. The excision in vivo was even less efficient (about 50%) at later developmental time points (E13.5-15.5 or E15.5-E17.5) and we did not see any effect on kidney size or number of glomeruli on postnatal day of life 1 (Supplemental Fig. 4A-D) . More efficient Gfra1 excision was limited due to embryonic toxicity from doses of 4HT greater than that used. Therefore, to further analyze the ability of the kidney to undergo branching morphogenesis in the absence of Gfra1 we established a kidney explant culture system with 4HT in the culture media. This provided excisional efficiency that was greater than 95% in the UB tip cells (Figs. 6  and 7B) . Additionally, the culture system allowed direct visualization of branching over time. Surprisingly even with near complete excision of Gfra1 from the ureteric epithelium the branching pattern appeared normal and Gfra1-null cells were able to colonize the UB tips. To further quantify branching deficits in Gfra1CKO cultures we compared UB tip numbers of Gfra1CKO and control reporter mice that express fluorescence reporter (Gfra1-EGFP or Hoxb7Cre -Rosa-YFP) to facilitate visualization of the branching tips during time-lapse culture ( Fig. 7A and B) . At 72 h of culture we observed a 16% decrease in the number of UB tips in Gfra1CKO compared to controls (Fig. 6C ). To overcome a potential confound of non-littermate reporter controls we also compared explant growth between the Gfra1CKO and control littermates by comparing their surface areas using phase contrast images at various time points during the culture. We used surface area for comparison as the littermates do not have a fluorescent reporter to facilitate quantification of UB tips. We observed a modest reduction (25%) in relative surface area beginning at 48 h of culture ( Fig. 7C and D) . Therefore, despite potent deletion of Gfra1 in the UB epithelium there was only a modest effect on branching morphogenesis.
Discussion
Gfra1 is an important protein for early development of many organ systems including initiation of the UB for normal metanephric kidney development in the mouse. Our studies address two critical aspects of Gfra1 in the urinary system by utilizing novel and innovative Gfra1 reporter, conditional, and tamoxifen inducible Cre mouse strains. We provide conclusive evidence that prior to UB budding Gfra1 in nonureteric epithelial structures such as the mesonephric mesenchyme cannot signal in trans and rescue UB budding. Therefore, Gfra1 activity in the WD is critical for UB induction. Second, by eliminating Gfra1 from the ureteric epithelium post UB induction we demonstrate that Gfra1 loss results in mild metanephric hypoplasia. This suggests branching is only partially dependent on Gfra1 signals. Our studies also provide evidence that the mechanism of reduced branching in Gfra1CKO mice is due to reduction in UB proliferation. Finally we note that pERK activity in UB tip cells is dependent on Gfra1 as cells without Gfra1 had almost no pERK signal.
Among the Gfra coreceptors, Gfra1 is the most relevant for kidney development because its germline deletion causes renal agenesis and no kidney defects are reported in other Gfranull mice (Airaksinen and Saarma, 2002; Airaksinen et al., 1999; Nishino et al., 1999; Rossi et al., 1999) . Based on this and studies in vitro showing severe effects on branching in kidneys cultured in the presence of Gdnf antibodies we expected that loss of Gfra1 would cause drastic defects in branching (Towers et al., 1998; Vega et al., 1996) . Therefore it was surprising that its loss in the majority of Gfra1CKO UB tips in vivo and near complete loss in the UB tips of explant cultures showed only moderate hypoplasia. This is in contrast to a critical role of Gfra1 in UB induction and suggests that Fig. 6 -Robust excision of Gfra1 in UB epithelium metanepheroi cultured ex-vivo. Confocal microscopy images obtained from EGFP (green) and Gfra1 (red) double immunofluorescence labeling of control (A) or Gfra1CKO (B) kidneys cultured for 90 h in presence of 4HT. Note robust green signal and only a few Gfra1-labeled (red arrow) cells in Gfra1CKO panels indicate highly efficient Gfra1 excision in the UB tip. There is only partial excision of Gfra1 in the cap mesenchyme (CapM). Scale bar 50 lm.
branching morphogenesis may rely on factors other than Gfra1. One possibility is continued activation of Ret by other Gfras such as Gfra2. There is no evidence in vivo that supports compensation of Gfra1 loss by Gfra2 in the kidney or enteric nervous system. We did not see any overt changes in Gfra2 expression in the Gfra1CKO mice that would suggest Gfra2 is compensating for Gfra1 loss post UB induction. Definitive proof to rule out Gfra2's compensatory role would require double Gfra1CKO/Gfra2-null mice. Another possibility is Ret independent roles of GFLs as GFLs can activate NCAM in the absence of RET in the nervous system (Paratcha et al., 2003) . This may be unlikely as no other GFL or Gfra coreceptor or NCAM knockout have a renal phenotype (Airaksinen and Saarma, 2002; Paratcha et al., 2003) and multiple compound double homozygous mice on a Gfra1CKO background will be required for definitive confirmation.
Another reason for modest effect is that the cells where Gfra1 is not completely eliminated are able to partially compensate as seen by their increased proliferation and pERK activity. This suggests extraordinary capacity of unaffected UB tip cells to compensate. This is unlike the enteric nervous system where Gfra1 loss in 70% of neurons led to complete aganglionosis of the colon (Uesaka et al., 2007) . To minimize this confound, the explant culture system was used and near complete excision of Gfra1 in the UB epithelium was achieved and yet only a modest role of Gfra1 was observed indicating that the kidney relies on multiple signaling mechanisms for branching morphogenesis. The reduction in kidney size between Gfra1CKO and littermate control was 25% in explant culture versus 20% in vivo despite more potent deletion in the culture system. This may be due to a threshold of Gfra1 levels required in the UB tip beyond which additional loss ) metanephroi compared to phase and fluorescent images of Gfra1CKO dissected at E12.5, cultured in the presence of 4HT. (E) Bar graph shows comparison between surface areas (mean number of pixels per metanephros ± s.e.m.; * P < 0.01 by t-test) of Gfra1CKO (n = 7) and littermate controls (n = 12) at indicated time points. Scale bar: 250 lm (inset scale bar 125 lm).
does not significantly impact kidney growth during branching.
We cannot exclude the possibility that Gfra1 from the metanephric mesenchyme (MM) (trans-signaling) could compensate for Gfra1 loss in the UB tips during branching morphogenesis as the excision efficiency in the MM was low due to weak expression in the MM compared to that in the UB tip. Although, we believe trans-signaling is unlikely because: 1) during pre UB induction Gfra1 in mesonephric mesenchyme does not compensate for its loss; and 2) elimination of all trans Gfra1 expression did not affect kidney development (Enomoto et al., 2004) . To completely rule out a role of trans-Gfra1 signaling in branching morphogenesis experiments with inducible Cre strains with potent activity in both the MM and UB are needed.
Numerous receptor tyrosine kinases (RTK) are expressed in the metanephric kidney that may have a role in later kidney development including receptors for FGF ligands and the RTK Met (Bates, 2011; Song et al., 2011) . Therefore, a more likely scenario for the mild hypoplasia is compensation by other RTKs. Recent studies have identified non-Ret pathways involved in kidney development and branching morphogenesis. One study has shown that FGF10/FGFR2 tyrosine kinases signaling can compensate for branching morphogenesis in the absence of Ret or GDNF and Spry1 (Michos et al., 2010) . The b-catenin pathway was also suggested as an alternative mechanism for Ret-independent branching (Kiefer et al., 2010) . In support of redundant pathway involvement we noted that expression of several downstream mRNA targets of Ret were not changed in Gfra1CKO kidneys. Although a positive feedback mechanism among Ret signaling components has been reported (Barak et al., 2011; Pepicelli et al., 1997 ) the mechanism of reduced Ret mRNA transcripts observed in the Gfra1CKO mice needs further investigation.
Our results show that Gfra1's importance in ureteric epithelium during kidney development decreases with time. It is critical in UB induction where its loss causes agenesis and less important during early branching where its loss results in modest hypoplasia. These different roles of Gfra1 during preUB and postUB induction are novel observations to our knowledge. Studies investigating genes known to be important in kidney ontogeny at different developmental stages are limited. Among these WT1 has differential functions at different developmental stages (Hu et al., 2011) . Additionally, Gfra1's importance at different stages during development depends on the organ system. In the mouse gut, at E11.5-E13.5 Gfra1 is critical for enteric neuron proliferation, after E15.5 it has an essential role for neuron survival only in the colon, and after postnatal day 5 it is not essential (Uesaka et al., 2007) . Therefore, in addition to a time-specific requirement, organs have differential susceptibility to Gfra1 loss.
We previously reported that Ret signaling is a major regulator of pERK in the Wolffian duct during UB bud formation (Hoshi et al., 2012) . Even post-UB induction Gfra1 is a major regulator of ERK1/2 activity as there was near complete loss of pERK in cells that had no Gfra1. An important observation from our time-lapse kidney culture experiments is that EGFP-positive cells were maintained throughout the branching distal UB tips. Previous studies using a chimeric system demonstrated that cells lacking Ret are less competent to colonize the UB tips compared to wild-type cells (Chi et al., 2009) . The presence of Gfra1-null cells in the branching UB tips suggests that Gfra1 is not necessary for tip colonization.
In conclusion, our studies demonstrate that Gfra1, a critical component of the Ret signaling complex, is required in the WD epithelium during early UB induction and cannot be compensated by trans-activity from nonepithelial tissues during this developmental stage. It has a modest role in branching that is associated with decreased cell proliferation and ERK activity. Our results provide further support for redundant pathways other than Gdnf-Gfra1-Ret signaling to ensure on-going branching morphogenesis. Ultimately further studies with Gdnf and Ret conditional models are needed to establish the role of the entire Gdnf-Gfra1-Ret signaling complex after budding in vivo.
4.
Experimental procedures
Animals
Institution approved protocols were followed for all animal studies and were compliant with National Institutes of Health guidelines. For timed pregnancies, the day of the copulatory plug was defined as embryonic day 0.5 (E0.5). To use EGFP as a surrogate for Gfra1 expression (Gfra1 reporter) we bred Gfra1 floxEGFP/+ mice (Uesaka et al., 2007) with b-actinCre mice (Meyers et al., 1998) . This deleted the floxed Gfra1 allele and expressed the EGFP reporter allele from cells that express bactinCre (Gfra1 EGFP/+ ). Genotyping of the reporter Gfra1 EGFP/+ was performed with forward primer P1 (Uesaka et al., 2007) and reverse primer P8428 (Jain et al., 2006b) . For experiments to determine the cell autonomous roles of Gfra1 in the epithelial lineage we bred Gfra1 heterozygous mice (Gfra1
) in which one of the alleles has been knocked out and instead tau-lacZ (TLZ) is knocked-in and expressed from the Gfra1 locus (Enomoto et al., 2004) ; MGI ID: 2449038] mice to facilitate visualization of the UB tips (Soriano, 1999; Yu et al., 2002) .
To express the tamoxifen-inducible Cre allele from Gfra1 locus (Gfra1-CreERT2) we knocked-in CreERT2 cDNA into the Gfra1 locus using the same strategy as was previously used to target this locus in generating Gfra1 null and conditional mice. Briefly, the CreERT2 gene cassette was inserted into the second exon of the previously described Gfra1 targeting vector (Enomoto et al., 2004; Uesaka et al., 2007) , the Gfra1-CreERT2 construct was injected into embryonic stem cells, cells that underwent homologous recombination were selected, injected into blastocysts and high percentage chimeras were bred to obtain Gfra1-CreERT2 heterozygous mice. Heterozygous Gfra1-CreERT2 were bred and Homozygous Gfra1-CreERT2 mice were born with renal agenesis similar to the expected phenotype in Gfra1 nulls further confirming successful integration into the Gfra1 locus (Cacalano et al., 1998; Enomoto et al., 1998) . Detailed characterization of this Gfra1-CreERT2 mouse strain will be provided elsewhere. Genotyping was performed using the common forward primer P1, reverse wild-type primer P2 (Uesaka et al., 2007) Cre recombinase mediated deletion pregnant mice were injected (intraperitoneal) with 4-hydroxy-tamoxifen (4HT) (Sigma) (a cumulative dose of 3 mg/30 g) dissolved in autoclaved corn oil. A single dose of 4HT at E11.5 or E12.5 or divided over two injections at E11.5 or E12.5 did not affect the final phenotype therefore these data were combined. Doses greater than 3 mg/30 g resulted in toxicity. We observed Gfra1 excision 8-10 h after 4HT injection as judged by EGFP immunofluorescence. For late excision experiments pregnant mice were injected with a cumulative dose of 3 mg/30 g at or between E13.5-15.5 or E15.5-17.5. Gfra1
CreERT2/+
, and Gfra1 floxEGFP/floxEGFP mice were maintained on a pure C57BL/6 background.
Immunological analysis
Paraformaldehyde fixed (PFA) whole GU tract or metanephric kidneys were dissected, blocked (PBS containing 0.2% non-fat dry milk, 1% BSA, 0.3%Triton X-100) overnight at 4°C followed by primary antibody incubation for 2 days at 4°C, washed (PBS with 0.3% Triton X-100) and then incubated with secondary antibody overnight at 4°C. Specimens were visualized with Eclipse 80i (Nikon) compound upright microscope or SMZ1500 dissecting microscope (Nikon). Images were captured using CoolSnapES camera (Roper Scientific), processed, and analyzed with NIS-Elements (Nikon) and Adobe Photoshop CS3 software. Confocal microscopy images were obtained on the Eclipse 80i (Nikon) equipped with D-EclipseC1 confocal system (Nikon). For immunohistochemistry on paraffin-embedded tissue sections antigen retrieval was used by boiling the slides immersed in EDTA (1 mM) or citrate buffer (pH 6.0) for 15 min. In some cases of Gfra1 immunohistochemistry on paraffin sections, antigen unmasking was done overnight by immersion in 20 lM TrisChloride (pH 9.0) at 70°C. Blocking, antibody staining, image capture and analysis were performed as described above. Frozen sections were analyzed in a similar fashion. For cryoprotection, previously fixed tissues were immersed in 30% sucrose for at least 24 h. Specimens were embedded in Optimal Cutting Temperature (OCT) compound (Suskura Finetek) and stored at À80°C. Cryosections (10 microns) were cut in series on a cryostat (Leica CM 1850). Slides were fixed in fresh 4% PFA for 6-10 min at room temperature before starting the immunostaining procedure described above.
Primary antibodies used were: GFP (chicken, 1:500 dilution, Aves); Gfra1 (goat, 1:50, Neuromics); E-cadherin (goat, 1:100, R&D); phospho-histone H3 (mouse, 1:100, Cell Signaling); phospho-Erk 1/2 (rabbit, 1:100, Cell Signaling); Pax-2 (rabbit, 1:100, Convance); WT1 (mouse, 1:100, Dako); Six2 (rabbit, 1:100, Proteintech). Secondary antibodies (Jackson Immuno Research) used were: DyeLight-488-conjugated chicken (1:1000); Cy3 conjugated IgG (goat or rabbit or mouse, 1:100); Cy5 conjugated IgG (goat or rabbit or mouse 1:100).
4.3.
Quantitative real-time PCR analysis E14.5 whole kidneys were dissected in sterile PBS, immediately placed in 1 ml of Trizol (Invitrogen), and homogenized (PowerGen 125) for RNA extraction according to manufacturer's instructions. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed in triplicate with Applied Biosystems 7900 HT Sequence Detection System using Fast SYBR Green technology. All primer sets were designed using Primer Express 3.0 software (Applied Biosystems) and purchased from Integrated DNA Technologies (IDTÒ) (sequences listed in Supplemental Table 1 ). Glyceraldehydes-3-phosphate dehydrogenase (GAPDH) was used for normalization. PCR parameters were: initial degeneration at 95°C for 5 min followed by 40 cycles of denaturation at 95°C for 10 s, annealing/extension at 60°C for 30 s. Primer validation was done using dissociation curve analysis to exclude primer dimer formation prior to and after all the experiments. Analysis was performed by absolute quantitification method and levels were expressed after normalization with Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression (QTmean sample /QTmean GAPDH ). Statistical significance was determined using the Student t-test.
Histomorphic analysis
Mouse GU tracts were dissected at indicated ages, fixed in fresh 4% PFA. Serial histological analysis with hematoxylin and eosin (H&E) staining was performed as previously described (Jain et al., 2004) . Glomerular counts were performed on paraffin sections as previously described (Jain et al., 2006a) . Briefly, kidneys were sectioned in their entirety; all glomeruli were counted from H&E sections at 120 micron intervals. Cross-sectional area was calculated on whole metanephric kidneys from mutant and littermate controls with NIS-Elements BR 3.2 (Nikon) software (Michos et al., 2010) . Whole mount ureteric tip counts were performed on E-cadherin (IHC) stained kidneys. Using a SMZ1500 dissecting microscope, images of mutant (Gfra1CKO) and littermate controls were captured under the same magnification using CoolSnapES camera (Roper Scientific). Ureteric bud tips appearing within a single unit area of a grid placed over the center of the kidney were counted in a blinded fashion by two individuals (the results were averaged) using the NIS-Elements software (Nikon).
4.5.
Proliferation and activated-Erk quantification and apoptosis assay Proliferation analysis was performed by measuring the mitotic index of ureteric tip epithelial cells at E14.5 on paraformaldehyde fixed paraffin or OCT embedded sections. Briefly, sections were double or triple immune-stained for phosphohistone H3 (phh3), E-cadherin, and EGFP. Phospho-histone H3 cells double stained with E-cadherin and/or EGFP were counted on Gfra1CKO and controls. For overall UB tip proliferation (mitotic index), pHH3 cells within a discrete UB tip were counted against the total number of epithelial cells per tip (pHH3 and E-cadherin+/E-cadherin+). To quantify proliferation of Gfra1 negative cells (express EGFP reporter), pHH3
and EGFP double positive cells were counted and compared against the total number of EGFP positive cells per UB tip (pHH3+ EGFP+/EGFP+). Sections from 7 control and 11 mutant kidneys were analyzed. Total counts were >2500 UB tip cells in the control and >4000 UB tip cells in the mutant. Quantification of ERK activity was obtained at E14.5 on paraformaldehyde fixed paraffin or OCT embedded sections in the same manner as above. Sections were double (pERK and EGFP) or triple immune-stained (pERK, E-cadherin, and EGFP or pERK, Gfra1, and EGFP). Sections from 4 control and 5 mutant kidneys were analyzed. Total counts were >1400 UB tip cells in the controls and >2000 in the mutants. Apoptosis analysis was performed using TUNEL staining on paraffin sections as previously described (Jain et al., 2006a ).
Metanephric organ cultures
Metanephric kidneys were dissected at the indicated time points and cultured. Culture was performed on BD Falcon 0.4 lm pore polyethylene terephthalate (PET) tack-etched membrane inserted into 6 well culture plate as previously described and 4HT (final concentration 1 lM) was added to the medium in inducible deletion experiments (Rogers et al., 1991) . Time-lapse microscopy was performed in a specialized culture chamber with 5% CO2 air mixture. FITC and phase images were captured every 30 min (HQ2, Photometrics) with respective filters. Images were processed using Metamorph software. For quantification of ureteric bud tips we cultured E12.5 metanephric kidneys for 72 h and all tips were counted in a blinded fashion from images at the indicated times during culture. Kidneys with 9-13 UB tips at the beginning of culture from each genotype were used for this analysis. To facilitate visualization of the UB tips at the start of culture pregnant mothers were injected with 4HT (intraperitoneal) at E11.5. There was no appreciable leakiness of Cre without 4HT as seen by no EGFP signal when 4HT injection in vivo was omitted (Fig. 7D) . Culture media was changed every 48 h. Surface area was determined by number of pixels present in manual traces of the outline of the phase contrast image using Metamorph software at the time points indicated. Each kidney at each time point was traced three times and the average was used.
Statistical analysis
Sample size was three or more for each genotype at each age reported. Statistical significance for all studies was determined by the Students t-test.
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